Inhibition of the signalling kinase JAK3 alleviates inflammation in monoarthritic rats
Open Access
- 22 March 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 164 (1) , 106-118
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT PathwayPharmaceuticals, 2010
- NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3Molecular Cancer, 2010
- New insights into the regulation of T cells by γc family cytokinesNature Reviews Immunology, 2009
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- Therapeutic potential of JAK2 inhibitorsHematology-American Society Hematology Education Program, 2009
- Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancerEuropean Journal of Cancer, 2008
- Pharmacological and therapeutic effects ofBerberis vulgarisand its active constituent, berberinePhytotherapy Research, 2008
- Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritisArthritis Research & Therapy, 2008
- Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatmentAnnals of the Rheumatic Diseases, 2006